DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Seckel syndrome 8 — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSeckel syndrome 8 maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for seckel syndrome 8 is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
A 7-year-and-3-month-old Chinese boy with Seckel syndrome carried compound heterozygous c.1535T>A (p.L512X) and c.3346-5T>C (splicing) mutations in the CEP152 gene, inherited from his mother and father respectively. His parents and two sisters were phenotypically normal. The proband had proportioned dwarfism, microcephaly, a “bird head” appearance (narrow and backward forehead, prominent and protruded eyes, beak-shaped nose, microretrognathia), high-arched palate, enamel dysplasia, hypodontia, and mental retardation. These mutations were newly described and expanded the CEP152 mutation spectrum.
A 12-year-old male with Seckel syndrome presented with unilateral secondary childhood glaucoma that had already caused advanced optic disc damage and visual deterioration. Glaucoma is a rare ophthalmic manifestation in Seckel syndrome; the authors recommended early screening to prevent vision loss. A separate case report of a 19-year-old male described the typical clinical, radiographic and dental features of Seckel syndrome, including primordial dwarfism, microcephaly, mental retardation, and the characteristic bird-headed facial appearance, with autosomal recessive inheritance and equal sex occurrence.
A 2016 review noted that Seckel syndrome belongs to the Microcephalic Primordial Dwarfisms, a clinically heterogeneous group. The underlying genetic defects identified so far point to requirements for optimal cell cycle control and DNA replication for normal human development. The review also stated that the condition has often been mis- or over-diagnosed.
No treatment or intervention for Seckel syndrome was tested or reported in any of these abstracts. What is missing is any clinical trial data, any drug tested in patients, any systematic screening protocol for glaucoma in this population, and any stratification of patients by genotype to predict which complications arise.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
PubMed · 2019 · 2 citations
[Analysis of clinical feature and genetic mutation in a Chinese family affected with Seckel syndrome].
AbstractOBJECTIVE: To explore the clinical characteristics and genetic mutation in a family affected with Seckel syndrome. METHODS: Clinical data of the proband and his family members were collected. Potential mutations were detected by high-throughput sequencing and Sanger sequencing. RESULTS: The proband, a 7-year-and-3-month-old boy, has featured proportioned dwarfism, microcephaly, "bird head" appearance (narrow and backward forehead, prominent and protruded eyes, beak-shaped nose and microretrognathia), high-arched palate, enamel dysplasia, hypodontia, and mental retardation. His parents and two sisters were all phenotypically normal. The proband was found to harbor compound heterozygous c.1535T>A (p.L512X) and c.3346-5T>C (splicing) mutations of the CEP152 gene, which were respectively inherited from his mother and father. CONCLUSION: The clinical features and genetic mutation of a case with Seckel syndrome were delineated. The newly discovered mutations have expanded the spectrum of CEP152 gene mutations.
European Journal of Ophthalmology · 2021 · 2 citations
Secondary Childhood glaucoma – a rare association in Seckel syndrome
AbstractA case of 12-year-old male with Seckel syndrome, presented with unilateral glaucoma leading to advanced disc damage hence, visual deterioration. Seckel syndrome being a rare inherited disorder characterized by growth delay and unique facial features, had been infrequently reported for ophthalmic anifestation especially glaucoma. Though glaucoma is a rare association in Seckel syndrome, screening at an early stage could help in preventing vision loss.
Journal of Dr. YSR University of Health Sciences. · 2018 · 1 citations · open access
Seckel syndrome: A case report of the rare syndrome
AbstractSeckel syndrome is a rare genetic disorder characterized by marked intra-uterine growth retardation (primordial dwarfism) and post natal dwarfism, microcephaly, mental retardation and typical facial features with a 'bird-headed' appearance. The syndrome has autosomal recessive inheritance with equal male and female sex occurrence. Here is an interesting case of a nineteen years old male patient, presented with various clinical manifestations, typical radiographic features and characteristic dental manifestations correlated with the literature. A thorough knowledge aids in better diagnosis, proper management and prevention of disastrous complications arising from this extremely rare inherited disorder, the Seckel syndrome.
Oxford University Press eBooks · 2016 · 0 citations
Seckel Syndrome
AbstractSeckel syndrome belongs to the family of Microcephalic Primordial Dwarfisms (MPDs), a clinically heterogeneous group of conditions associated with growth retardation, microcephaly, characteristic skeletal features and additional abnormalities. Over the last decade or so the underlying genetic defects for some MPDs have started to emerge. So far, these defects collectively highlight the requirement for optimal cell cycle control and progression including DNA replication for normal human development. In this chapter I will overview the genes implicated in Seckel syndrome. I will detail the clinical presentation of this disorder; contrasting it to the other overlapping MPDs, and describe current models underlying the molecular pathogenesis of the associated genetic defects, highlighting their inter-related and associated biological impacts. But first, I will provide some background to illuminate the precise origin of Seckel syndrome. My intention here is to place its origin or more precisely, its evolution, into some context, with the aim of helping to explain why this condition has often been mis- and/or over-diagnosed.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
